These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26729900)
21. [Advances in the treatment of Duchenne muscular dystrophy]. Ortez C; Natera de Benito D; Carrera García L; Expósito J; Nolasco G; Nascimento A Medicina (B Aires); 2019; 79 Suppl 3():77-81. PubMed ID: 31603849 [TBL] [Abstract][Full Text] [Related]
22. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. Atmanli A; Chai AC; Cui M; Wang Z; Nishiyama T; Bassel-Duby R; Olson EN Circ Res; 2021 Sep; 129(6):602-616. PubMed ID: 34372664 [TBL] [Abstract][Full Text] [Related]
23. Toward the correction of muscular dystrophy by gene editing. Olson EN Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34074727 [TBL] [Abstract][Full Text] [Related]
28. Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy. Willcocks RJ; Forbes SC; Walter GA; Sweeney L; Rodino-Klapac LR; Mendell JR; Vandenborne K JAMA Netw Open; 2021 Jan; 4(1):e2031851. PubMed ID: 33394000 [TBL] [Abstract][Full Text] [Related]
29. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy. Maruyama R; Echigoya Y; Caluseriu O; Aoki Y; Takeda S; Yokota T Methods Mol Biol; 2017; 1565():201-213. PubMed ID: 28364245 [TBL] [Abstract][Full Text] [Related]
30. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon. Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032 [TBL] [Abstract][Full Text] [Related]
31. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713 [TBL] [Abstract][Full Text] [Related]
32. [Mutation-specific treatments for Duchenne muscular dystrophy]. Matsuo M; Takeshima Y Brain Nerve; 2009 Aug; 61(8):915-22. PubMed ID: 19697880 [TBL] [Abstract][Full Text] [Related]
36. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. Rodino-Klapac LR; Janssen PM; Montgomery CL; Coley BD; Chicoine LG; Clark KR; Mendell JR J Transl Med; 2007 Sep; 5():45. PubMed ID: 17892583 [TBL] [Abstract][Full Text] [Related]
37. [The Emeritus Dinosaur's viewpoint - The road to hell of gene therapists is paved with POC]. Kaplan JC Med Sci (Paris); 2015 Nov; 31 Spec No 3():41-4. PubMed ID: 26546933 [No Abstract] [Full Text] [Related]